[Expression of miR-155-5p in Wilms tumor and its regulatory role in proliferation, migration and apoptosis of Wilms tumor cells in vitro]

Nan Fang Yi Ke Da Xue Xue Bao. 2019 Dec 30;39(12):1476-1481. doi: 10.12122/j.issn.1673-4254.2019.12.12.
[Article in Chinese]

Abstract

Objective: explore the expression of miR-155-5p in Wilms tumor and its effect in regulating the proliferation, migration and apoptosis of Wilms tumor cells.

Methods: Specimens of tumor tissues and paired adjacent tissues were obtained from 40 patients with Wilms tumor for detection of the expression levels of miR-155-5p using RT-qPCR. Wilms tumor cell line G401 was transfected with miR-155-5p mimics and miR-155-5p inhibitor to induce miR-155-5p over-expression and its inhibition, respectively, and the changes in the cell proliferation, migration and apoptosis were assessed using cell counting kit-8 (CCK-8), wound healing assay and fl ow cytometry.

Results: RT-qPCR showed that the expression of miR-155-5p decreased significantly in Wilms tumor tissues as compared with normal kidney tissues and was significantly associated with TNM stage (P < 0.05). In G401 cells, over-expression of miR-155-5p significantly inhibited the cell proliferation and migration and promoted cell apoptosis (P < 0.05), and down-regulation of miR-155-5p obviously enhanced the proliferation and migration and suppressed apoptosis of the cells (P < 0.05).

Conclusions: miR-155-5p is down-regulated in Wilms tumor and its expression level is correlated with TNM stage. miR-155-5p participates in the progression of Wilms tumor by inhibiting the proliferation and migration and promoting apoptosis of the tumor cells, and may serve as a novel biomarker for diagnosis, therapy and prognostic evaluation of Wilms tumor.

目的: 探讨miR-155-5p在肾母细胞瘤中的表达及其对肾母细胞瘤细胞增殖、迁移及凋亡能力的影响。

方法: 收集40例肾母细胞瘤患者的肿瘤组织及其相对应的瘤旁组织,瘤旁组织作为正常对照组,应用RTqPCR检测肾母细胞瘤组织和正常瘤旁肾脏组织中miR-155-5p的表达水平;在肾母细胞瘤细胞株G401中,运用脂质体转染技术过表达及抑制miR-155-5p;采用CCK-8实验检测肾母细胞瘤细胞增殖能力的变化;划痕实验检测肾母细胞瘤细胞迁移能力的变化;流式细胞术检测肾母细胞瘤细胞凋亡能力的变化。

结果: RTqPCR结果显示肾母细胞瘤肿瘤组织中miR-155-5p的表达水平显著低于正常肾脏组织,且miR-155- 5p的表达与肾母细胞瘤的临床分期呈负相关,差异有统计学意义(P < 0.05);在人肾母细胞瘤细胞G401中上调miR-155-5p表达能够显著抑制肿瘤细胞的增殖和迁移,促进凋亡(P < 0.05);下调miR-155-5p表达能够显著促进肿瘤细胞的增殖和迁移,抑制凋亡(P < 0.05)。

结论: miR-155-5p在肾母细胞瘤患者肿瘤组织中表达显著下调,且其表达量与临床分期呈负相关;miR-155-5p可抑制肾母细胞瘤细胞增殖和迁移,促进细胞凋亡;miR-155-5p有望成为肾母细胞瘤诊断、治疗和预后评估的一个新的潜在标志物。

Keywords: Wilms tumor; apoptosis; miR-155-5p; migration; proliferation.

MeSH terms

  • Apoptosis
  • Cell Movement
  • Cell Proliferation
  • Humans
  • Kidney Neoplasms* / genetics
  • MicroRNAs / genetics*
  • Neoplasm Invasiveness
  • Wilms Tumor* / genetics

Substances

  • MIRN155 microRNA, human
  • MicroRNAs

Grants and funding

重庆市技术创新与应用示范一般项目(cstc2018jscxmsybX0091);国家临床重点专科建设项目(国卫办医函[2013]544号)